Track the Theralase Technologies Inc. share price and the full directors' dealings record of the company, a listed equity based in Canada. Shares are listed on the CA market, under the supervision of SEDI. Market capitalisation: €57.4m. The latest transaction was filed on 31 August 2026 (53 - Grant of warrants). Among the most active insiders: Dumoulin-White, Roger John. Every trade is free.
17
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,388 of 29,063 companies
30.3
score / 100
Value
19
Quality
41
FCF yld-6.0%
Earn yld-7.4%
EV/EBITDA·
ROE-93%
Gross mgn62%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,000,000 shares@ CA$0.265100.0% of flowOptionsTSXSEDI:4761476
17 of 17 declarations
About Theralase Technologies Inc.
Theralase Technologies Inc. is a Canadian company focused on developing medical technologies, particularly laser treatment systems. It aims to eradicate cancer and manage pain.